ChenGuang Biotech Group Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, ChenGuang Biotech Group stock has a consensus rating of "Strong Buy" and an average price target of ¥13.44. The average 1-year stock price forecast is 38.41% higher than the current stock price, while the lowest is ¥8.65 (-10.92%) and the highest is ¥16.00 (+64.78%).

Price Target: ¥13.44 (+38.41%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	¥8.65	¥13.44	¥15.66	¥16.00
Change	-10.92%	+38.41%	+61.28%	+64.78%

Analyst Ratings

The average analyst rating for ChenGuang Biotech Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Dec '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	2	2	2	2	3
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	4

Financial Forecast

Revenue This Year

6.93B

from 6.56B

5.63%

from 6.56B

Revenue Next Year

7.65B

from 6.93B

10.47%

from 6.93B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.87B	6.30B	6.87B	6.99B	6.56B	6.93B
Revenue Growth	24.55%	29.18%	9.14%	1.79%	-6.22%	5.63%
Gross Profit	698.53M	843.87M	799.37M	459.36M	824.38M	989.58M
Gross Margin	14.33%	13.40%	11.63%	6.57%	12.57%	14.28%
Operating Income	379.05M	448.71M	480.92M	124.10M	412.29M	544.68M
Net Income	351.51M	434.03M	479.72M	94.05M	368.87M	456.85M
Dividend / Share	0.13	0.16	0.13	0.13	0.30	0.37
Dividend Growth	-	23.08%	-18.75%	-	130.77%	23.85%
No. Analysts	-	-	-	-	-	1

Financial currency is CNY.

Revenue Forecast

Revenue	2026	2027	2028
High	6.9B
Avg	6.9B
Low	6.9B

Revenue Growth

Revenue Growth	2026	2027	2028
High	5.6%
Avg	5.6%
Low	5.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-